Trial Profile
An Exploratory Clinical Study to Evaluate the safety and Skin Tolerability of Multiple Formulations of Once Weekly Investigational Transdermal Delivery System in Healthy Volunteers
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 18 Dec 2018
Price :
$35
*
At a glance
- Drugs Memantine (Primary)
- Indications Alzheimer's disease
- Focus Adverse reactions
- 18 Dec 2018 Status changed from planning to recruiting.
- 21 Sep 2016 New trial record